Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Health Insurance Pets Animals
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Zealand Pharma A/S UnitedHealth Group Inc Biotech and Pharmaceuticals
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Health care industry Biotech and Pharmaceuticals Sanofi SA
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Zealand Pharma A/S Breaking News: Markets Europe News
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Drugs Employee benefits Employee healthcare benefits
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Pfizer Inc Novo Nordisk A/S US: News
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Business News Science Biotechnology
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Eli Lilly and Co US: News Mergers
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Earnings Biotech and Pharmaceuticals Breaking News: Markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags 5 Things to Know JetBlue Airways Corp Boeing Co
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Biotechnology Biotech and Pharmaceuticals Sanofi SA
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Business News Bayer AG Sanofi SA
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Investing Breaking News: Investing Eli Lilly and Co
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Breaking News: Politics Pharmaceuticals Health & Science
From CNBC.com News
Here are the big health sector themes to watch next year
Tags UnitedHealth Group Inc CVS Health Corp Eli Lilly and Co
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Amgen Inc Pharmaceuticals Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy FedEx Corp Technology
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Companies Breaking news Business
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Business News Science Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Biotech and Pharmaceuticals Biotechnology Business News
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Economy Breaking News: Markets Breaking News: Investing
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Business News Investment Strategy Investment strategy
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Biotechnology Biotech and Pharmaceuticals Science
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Novo Nordisk A/S Business News Eli Lilly and Co
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Business Health care industry Companies
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Investment strategy Investment Strategy Business
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pharmaceuticals Health & Science Pfizer Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Politics Target Corp Markets
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Pharmaceuticals Health & Science Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.